GlassScriptPhysician profile
Daniel I Fremed
NPI 1548536436
$21,640.79
in general payments reported to CMS, 2019-2025
30 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,841 · 2020: $1,335 · 2021: $1,585 · 2022: $2,947 · 2023: $3,941 · 2024: $7,446 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,400 · Food and Beverage: $6,016 · Consulting Fee: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,400.00 |
| Food and Beverage | $6,016.01 |
| Consulting Fee | $516.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $5,502.61 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $4,368.67 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| W. L. Gore & Associates, INC. | $1,751.72 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis |
| Medtronic, INC. | $1,695.18 | 2021-2025 | Hawkone, Endurant Iis, Abre |
| Endologix LLC | $1,123.99 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Cardiovascular Systems INC. | $1,008.73 | 2019-2022 | |
| Silk Road Medical, INC. | $918.66 | 2019 | |
| Bard Peripheral Vascular, INC. | $801.70 | 2020-2025 | Venclose Maven Catheter, Venovo |
| Cook Medical LLC | $631.76 | 2019-2023 | Zenith Spiral-Z, Cook |
| Becton, Dickinson and Company | $516.67 | 2023 | |
| Boston Scientific Corporation | $383.07 | 2023-2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention |
| Lemaitre Vascular, INC. | $377.69 | 2022-2025 | Restoreflow, Artegraft Vascular Graft |
| Medtronic Vascular, INC. | $325.64 | 2019-2020 | |
| Limflow INC. | $312.04 | 2023 | Limflow System |
| Bolton Medical INC | $308.48 | 2022-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $217.68 | 2025 | Flowtriever, Revcore Thrombectomy Catheter, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $204.21 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Acera Surgical, INC. | $202.66 | 2024-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $191.52 | 2019-2021 | |
| Tactile Systems Technology INC | $177.25 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Abbott Laboratories | $89.25 | 2019-2023 | Diamondback Peripheral |
| Kci USA, INC. | $83.55 | 2019 | |
| Convatec INC. | $78.34 | 2024 | |
| Pfizer INC. | $76.43 | 2022-2025 | |
| Cvrx, INC. | $74.62 | 2023 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $74.39 | 2021-2023 | Xarelto |
| Lantheus Medical Imaging, INC. | $69.48 | 2024 | |
| Integra Lifesciences Corporation | $32.33 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $25.20 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Paratek Pharmaceuticals, INC. | $17.27 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fremed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.